Pharmaceutical preparations company · FY ends Jun · Revenue $195M · 3.37% margin · $4M FCF
Operating margin is thin at 5.34%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 14.2% YoY with margins expanding 3.2pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$195M
▲ +14.2% YoY
Net Income (TTM)
$6M
▲ +233.8% YoY
Op. Margin
3.37%
▲ +3.2pp YoY
ROIC
12.52%
▲ +16.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$4M
▲ +5.6% YoY
Op. Cash Flow (TTM)
$7M
▼ -2.6% YoY
Net Debt
-$2M
Net Cash Position
Cash & Equiv.
$12M
5Y CAGR: -0.4%
5Y CAGR: -7.7%
Continue Research